Multiple monoclonal antibodies have been shown to be effective for both prophylaxis and
therapy for SARS-CoV-2 infection. Here we aggregate data from randomized controlled …

While new vaccines for SARS-CoV-2 are authorized based on neutralizing antibody (nAb)
titer against emerging variants of concern, an analogous pathway does not exist for …

Background We systematically assessed beneficial and harmful effects of monoclonal
antibodies for coronavirus disease 2019 (COVID-19) treatment, and prophylaxis in …

Multiple studies of vaccinated and convalescent cohorts have demonstrated that serum
neutralizing antibody (nAb) titers correlate with protection against coronavirus disease 2019 …

Neutralizing antibodies for the treatment of COVID-19 | Nature Biomedical Engineering Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

Background Human monoclonal antibody (mAb) treatments are promising for COVID-19
prevention or therapy. The pre-exposure prophylactic efficacy of neutralizing antibodies that …

The coronavirus disease 2019 (COVID-19) pandemic has created a worldwide crisis and
inspired an urgent search for prevention and treatment of severe acute respiratory syndrome …

Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …

A correlate of protection for SARS-CoV-2 vaccines is urgently needed | Nature Medicine Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

The objective of this review was to examine the latest literature regarding the effectiveness
of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient …